production – Danish manufacturer Bavarian Nordic pledged on Thursday to supply two million additional doses of its serum by the end of the year, following the arrival of the first vaccines in Congo
Priority to the vaccine against MPOX. The Danish manufacturer Bavarian Nordic committed on Thursday to supply two million additional doses of its serum, the only one approved at this stage in Europe and the United States, by the end of the year, after the arrival of the first vaccines in the Democratic Republic of Congo (DRC), the focus of the epidemic.
“In response to the current epidemic and the strong demand from governments and organizations […] The company has prioritized the production of its vaccine, the laboratory announced in a press release.
265,000 doses arrived by plane in Kinshasa in the last few days
The DRC, by far the country most affected by the virus in the world, has recorded 22,000 cases and 716 deaths linked to MPOX since January, according to the latest figures from the Congolese Public Health Institute responsible for organizing the response to the epidemic.
Some 265,000 doses have arrived by plane in Kinshasa in recent days. These vaccines are to be deployed throughout the territory, four times the size of France, in preparation for a vaccination campaign that is due to begin next month. This vaccine is only intended for adults.
Bavarian Nordic ready to produce up to 11 million doses by 2025
(…) - 20minutes
Also read:
Botulism: Family meals, pesto… What we know about the five potential cases currently in intensive care
West Nile Virus: One Man Hospitalized and Ten Horses Dead in Hérault
Biogaran generic drugs will not be transferred to foreign ownership, Servier abandons the sale of its subsidiary
